Autoimmune lymphoproliferative syndrome with somatic Fas mutations
about
Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International WorkshopHow I treat autoimmune lymphoproliferative syndromeUse of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)Biomarkers and Algorithms for the Diagnosis of Vitamin B12 DeficiencyApproaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative SyndromeSomatic mutagenesis in autoimmunityAutoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosisCauses and consequences of the autoimmune lymphoproliferative syndromeMutations in the 3'-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD).Mutation analysis in primary immunodeficiency diseases: case studies.Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa.Diagnosis and management of autoimmune cytopenias in childhood.Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).Elevated double negative T cells in pediatric autoimmunityALPS-ten lessons from an international workshop on a genetic disease of apoptosisGenetics of follicular lymphoma transformation.Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.The power and the promise of restimulation-induced cell death in human immune diseases.Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasisNew advances in the diagnosis and treatment of autoimmune lymphoproliferative syndromeOnset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulationGene defects in the soma: some get it and some don't!Clues to immune tolerance: the monogenic autoimmune syndromesCutaneous vasculitis in patients with autoimmune polyendocrine syndrome type 1: report of a case and brief review of the literature.Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndromeThe expanding spectrum of the autoimmune lymphoproliferative syndromesNRAS mutation causes a human autoimmune lymphoproliferative syndrome.Laboratory evaluation of primary immunodeficienciesMolecular defects in T- and B-cell primary immunodeficiency diseases.Autoimmunity: basic mechanisms and implications in endocrine diseases. Part I.A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.Autoimmunity: twenty years in the Fas laneDeregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.Genetic defects of apoptosis and primary immunodeficiency.Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease.Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia.
P2860
Q24623371-DFE799C1-8332-4718-9169-5CC5A82EBF4EQ24632569-F862D4F3-D26B-4E4C-86E1-CAA588502C13Q24633207-541E21CB-2FD0-49FE-B56F-C0959D267C5BQ24643047-C19AE876-88EB-4843-9344-1933EA6EB788Q26742072-EC411EA0-EB1D-4AD3-B864-E4EF40FBEE1AQ26799956-5F2D66B8-194C-4352-83DD-8EE1D2254204Q26860815-C20DCA9E-D0A7-42E4-8511-36E93BD727E3Q28299956-CC3586C3-D3BC-435D-B66C-DE37F97BCA4DQ28300792-8E0F47C8-3D93-4400-8985-37C3C2B7482BQ33288896-0AF2381F-80A9-4DE5-9A80-FD928C05EAA2Q33386708-4360FA8A-50DD-4142-86EA-2A7BDEA6E74BQ33394404-46653A9D-9611-463E-AA33-063BFFF6168DQ33411497-38D6A3A7-0F41-49CC-833A-E2868CD15918Q33420245-3E8CBEB4-1D7B-46BC-B717-05619A8BF745Q33717456-6030D190-0FBD-4184-8A47-96D73A871C1AQ33807422-7BA9A74C-7E8E-476E-BE28-DEA270A34F06Q33910446-565314B5-FFE8-44AA-BD0B-9A09F52D8508Q33944255-5EFE1C48-76BB-4B08-81AC-77E8EA591ED0Q34009654-6474A22F-07FA-4332-9FC9-53DD121A969EQ34149957-E9394137-53EE-4819-8AFE-3EFC3A954676Q34239719-9734871F-22FE-44CC-AEE9-A53F54FBA7B7Q34428954-AD5EE363-B866-4A5E-8A52-AE6B63B5F331Q34429062-1CBEE392-A859-4F60-9992-D9AC7C72E1BAQ34440616-1FB83147-7F36-4097-A068-8B4CEA60DE3DQ34445745-D960CE7C-912D-4140-B35A-F58F9C4B92C4Q34513178-C0942CDB-3C8F-4003-BA0B-D31EF0FD82CDQ35130847-7A82AF2B-57E7-4CBF-AA98-E952B9D455AFQ35619447-2D2177F4-87F0-4F4C-B0C0-B27E24A33C29Q35829141-F0996DBE-6726-4ECA-873C-242F46209850Q36142583-18A9A40D-1C76-426B-92D0-F104452FD66BQ36302334-B2F57623-C6F3-45C6-9D21-B5E35749387CQ36522840-DA84EC4D-59E3-411D-8385-8FDA201A5073Q36595156-DAA39BFD-055B-4876-83A7-051A0FB20701Q36632364-58824729-5C23-4EC6-868D-7AD354872FC9Q36708937-FB4D99E7-76BC-430D-9872-F97B468B52B6Q37142878-F5959B12-FC17-48C1-846C-F774DF19DEEDQ37219274-D85587F1-9833-49EC-9781-48F1BE558B2DQ37272180-CEFA7DB2-DB67-414D-844F-8B0C275B0A47Q37298573-408F4A53-BF69-4F73-9DE5-BA169F1BF64BQ37377927-027D214F-8522-4BB9-90C8-BBADD789C97D
P2860
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@ast
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@en
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@nl
type
label
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@ast
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@en
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@nl
prefLabel
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@ast
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@en
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@nl
P2093
P50
P3181
P356
P1476
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
@en
P2093
Anne-Marie Prieur
Cédric Vonarbourg
Eliska Holzelova
Etienne Vilmer
Françoise Selz
Jirina Bartunkova
Stéphane Blanche
P304
P3181
P356
10.1056/NEJMOA040036
P407
P577
2004-09-30T00:00:00Z